Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4326
Core Molding Technologies
CMT
$216M
| $185K | ﹤0.01% |
9,996
+5,621
| +128% | +$123K |
|
4327
Aclaris Therapeutics
ACRS
$855M
| $185K | ﹤0.01% |
175,919
-58,231
| -25% | -$178K |
|
4328
Kopin
KOPN
$782M
| $185K | ﹤0.01% |
90,991
+14,600
| +19% | +$20.8K |
|
4329
Orchestra BioMed
OBIO
$250M
| $184K | ﹤0.01% |
20,141
+16,988
| +539% | +$116K |
|
4330
Universal Electronics
UEIC
$69.6M
| $183K | ﹤0.01% |
19,475
-6,513
| -25% | -$53.2K |
|
4331
GH Research
GHRS
$2.13B
| $183K | ﹤0.01% |
31,500
-32,090
| -50% | -$227K |
|
|
SILV
4332
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $183K | ﹤0.01% |
27,882
-175
| -0.6% | -$974 |
|
4333
LifeVantage
LFVN
$83M
| $182K | ﹤0.01% |
30,358
| – | – |
|
4334
Acumen Pharmaceuticals
ABOS
$168M
| $182K | ﹤0.01% |
47,347
+24,922
| +111% | +$74K |
|
4335
Dynagas LNG Partners
DLNG
$143M
| $181K | ﹤0.01% |
64,800
| – | – |
|
4336
CB Financial Services
CBFV
$188M
| $181K | ﹤0.01% |
7,613
+183
| +2% | +$4.04K |
|
|
VTYX
4337
DELISTED
Ventyx Biosciences
VTYX
| $181K | ﹤0.01% |
73,264
-154,956
| -68% | -$1.47M |
|
4338
Symbotic
SYM
$5.32B
| $180K | ﹤0.01% |
3,516
-4,492
| -56% | -$197K |
|
|
RDNW
4339
RideNow Group
RDNW
$264M
| $180K | ﹤0.01% |
22,126
+3,842
| +21% | +$24.6K |
|
4340
Bausch + Lomb
BLCO
$5.87B
| $179K | ﹤0.01% |
10,467
+10,283
| +5,589% | +$165K |
|
4341
FingerMotion
FNGR
$22.2M
| $178K | ﹤0.01% |
+44,344
| New | +$219K |
|
4342
BARK
BARK
$93.1M
| $178K | ﹤0.01% |
11,046
+7,984
| +261% | +$146K |
|
|
PLYA
4343
DELISTED
Playa Hotels & Resorts
PLYA
| $178K | ﹤0.01% |
20,562
-37,112
| -64% | -$279K |
|
4344
Invesco Semiconductors ETF
PSI
$2.49B
| $178K | ﹤0.01% |
3,591
| – | – |
|
4345
Gran Tierra Energy
GTE
$322M
| $177K | ﹤0.01% |
31,420
| – | – |
|
|
SGMO
4346
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $176K | ﹤0.01% |
324,387
+179,036
| +123% | +$82.5K |
|
4347
AdvisorShares Pure US Cannabis ETF
MSOS
$878M
| $176K | ﹤0.01% |
25,081
+81
| +0.3% | +$539 |
|
|
RPT
4348
Rithm Property Trust
RPT
$94.2M
| $175K | ﹤0.01% |
5,513
+4,169
| +310% | +$128K |
|
4349
Garrett Motion
GTX
$5.7B
| $174K | ﹤0.01% |
18,014
+320
| +2% | +$2.47K |
|
|
VOXX
4350
DELISTED
VOXX International Corporation Class A
VOXX
| $174K | ﹤0.01% |
16,291
+14,358
| +743% | +$142K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.